Doctors review past cases to gauge cancer Drug's impact
NCT ID NCT07238907
Summary
This study is looking back at the medical records of 102 adults with a type of blood cancer called B-cell acute lymphoblastic leukemia (B-ALL). Researchers want to understand how well and how safely the drug inotuzumab ozogamicin worked for these patients in real-world settings. No new treatments are being given; the study is only analyzing information from past care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
Conditions
Explore the condition pages connected to this study.